THE RELATIONSHIP BETWEEN MEDICATION COMPLIANCE AND CLINICAL OUTCOMES OF DYSLIPIDEMIA PATIENTS AT THE ARJASA COMMUNITY HEALTH CENTER
DOI:
https://doi.org/10.36858/ipj.v2i2.88Keywords:
Dyslipidemia, medication adherence, clinical outcomes, total cholesterol, Arjasa Community Health CenterAbstract
Dyslipidemia is a lipid metabolism disorder characterized by elevated total cholesterol, LDL cholesterol, and triglyceride levels, and/or decreased HDL cholesterol. In Indonesia, the prevalence of dyslipidemia among middle-aged adults (40–60 years) reaches 50.3% (Permatasari & Syauqy, 2022). Patient adherence to lipid-lowering medication plays a key role in controlling blood lipid profiles and preventing cardiovascular complications. This study aimed to analyze the relationship between adherence to antidyslipidemic medication and clinical outcomes among outpatient dyslipidemia patients at Arjasa Community Health Center. This study used a quantitative method with a cross-sectional observational design. The study was conducted in June 2026 at Arjasa Community Health Center, Jember Regency, using a total sampling technique involving 41 dyslipidemia patients who met the inclusion and exclusion criteria. Adherence was assessed using the MMAS-8 questionnaire, while clinical outcomes were evaluated based on total cholesterol levels obtained from medical records. Data were analyzed using the Chi-Square test.The majority of respondents (61.0%) were categorized as adherent, and 58.5% had normal total cholesterol levels (<200 mg/dL). The Chi-Square test showed a Pearson Chi-Square value of 22.913 with a p-value of 0.000 (<0.05), indicating a significant relationship between medication adherence and clinical outcomes. The contingency coefficient (C) of 0.599 indicated a moderately strong association. There is a significant relationship between adherence to antidyslipidemic medication and clinical outcomes among dyslipidemia patients at Arjasa Community Health Center. Higher levels of medication adherence are associated with a greater likelihood of achieving normal total cholesterol levels.
Key words: Dyslipidemia, medication adherence, clinical outcomes, total cholesterol, Arjasa Community Health Center.
References
Aman, A. M., Soewondo, P., Soelistijo, S. A., Arsana, P. M., Wisnu, W., & Z. H. (2021). Pengelolaan Dislipidemia di Indonesia 2021. PB PERKENI.
Anwar, V. A., & Hasan, D. (2019). Profil kepatuhan penggunaan obat antihiperlipidemia di salah satu rumah sakit swasta Jakarta.
Apriliany, F., Ikawati, Z., & Pramantara, I. D. P. (2021). Pengaruh komorbid dan jenis terapi terhadap outcome kolesterol total pasien dislipidemia.
Della, A., Subiyanto, P., & Maria, A. (2023). Faktor-faktor yang berhubungan dengan kepatuhan pengobatan pasien diabetes melitus tipe 2. Jurnal Kebijakan Kesehatan Indonesia, 7(2), 124–136.
Dunbar-Jacob, J., & Zhao, J. (2025). Medication adherence measurement in chronic diseases: A state-of-the-art review of the literature. Nursing Reports, 15(10), 1–18.
Fauziah, S., Syafhan, N. F., Puspitasari, A. W., & Kusumawardan, L. A. (2026). Kepatuhan minum obat, luaran klinis dan kualitas hidup pasien dislipidemia: Studi potong lintang.
JATIM. (2025). Profil Kesehatan Jawa Timur 2024.
Karr, S. (2017). Epidemiology and management of hyperlipidemia. American Journal of Managed Care, 23(Suppl. 9), S139–S148.
Kementerian Kesehatan Republik Indonesia. (2023). Dislipidemia.
Kementerian Kesehatan Republik Indonesia. (2024). Profil Kesehatan Indonesia.
Mach, F., Baigent, C., Catapano, A. L., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111–188.
Paulina, A., Angin, M. P., & Hidayaturahmah, R. (2023). Evaluasi penggunaan obat kolesterol pada pasien hiperlipidemia di instalasi rawat jalan Rumah Sakit Mutiara Bunda.
PERKENI. (2021). Panduan Pengelolaan Dislipidemia di Indonesia.
PERKI. (2022). Panduan Tata Laksana Dislipidemia.
Permatasari, Z., & Syauqy, A. (2022). Food consumption and dyslipidemia in middle-aged adults in Indonesia: A cross-sectional national study. Nutrition and Health.
Rahmadha, S., Muthoharoh, A., Ningrum, W. A., & Rahmatullah, S. (2022). Konseling apoteker meningkatkan kepatuhan pengobatan dan menurunkan kadar gula darah pasien DM tipe 2.
Raising, R., Hermawatiningsih, O. D., & Rumaolat, W. (2024). Efektivitas penggunaan obat dislipidemia terhadap kadar LDL pada pasien kardiovaskular penyebab stroke.
Siregar, M. S. R., & Boy, E. (2022). Faktor risiko pada pasien dislipidemia.
SKI. (2023). Survei Kesehatan Indonesia dalam Angka 2023.
World Health Organization. (2023). Raised Cholesterol. World Health Organization. (2025). Progress Report: Accelerating Prevention and Control of Cardiovascular Diseases in the South-East Asia Region.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ayu Putri MS, Eri Suyoko
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
